DNMT3A

UniProt ID: A0A9L0TK01
Organism: Equus caballus
Review Status: IN PROGRESS
πŸ“ Provide Detailed Feedback

Gene Description

DNMT3A is a conserved de novo DNA cytosine-5 methyltransferase associated with nuclear chromatin and gene-expression regulation. The selected horse model retains the ADD and catalytic domains but lacks a segment overlapping the end of the PWWP chromatin-reader domain, leaving its normal histone-guided genomic targeting uncertain. DNMT3A expression has been measured during horse testis development.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0000122 negative regulation of transcription by RNA polymerase II
IEA
GO_REF:0000107
ACCEPT
Summary: The retained DNMT3A catalytic machinery supports gene-expression regulation.
Reason: The ADD and methyltransferase domains are conserved, supporting targeted DNA methylation and transcriptional effects. A PWWP deletion can change genomic targeting without eliminating the broad regulatory function.
Supporting Evidence:
PMID:29414941
the DNMT3A-DNMT3L-DNA complex in which two DNMT3A monomers simultaneously attack two cytosine-phosphate-guanine (CpG) dinucleotides
PMID:23042785
DNMT3A recruitment is increased, with hypermethylation being associated with silencing of gene expression.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
share 97.3% identity among 873 paired residues.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
The ADD domain (human 482–614) and C-terminal methyltransferase domain (634–912) are retained.
PMID:30478443
Substitutions in the PWWP domain abrogate binding to the histone modifications H3K36me2 and H3K36me3, and alter DNA methylation in patient cells.
GO:0000775 chromosome, centromeric region
IEA
GO_REF:0000107
UNDECIDED
Summary: Normal heterochromatin targeting is uncertain for this PWWP-altered model.
Reason: The selected sequence lacks human339–374, overlapping the PWWP reader. Human PWWP variants alter histone recognition and genomic methylation, so exact chromatin targeting cannot be inferred from an intact catalytic domain.
Supporting Evidence:
PMID:30478443
Substitutions in the PWWP domain abrogate binding to the histone modifications H3K36me2 and H3K36me3, and alter DNA methylation in patient cells.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
The ADD domain (human 482–614) and C-terminal methyltransferase domain (634–912) are retained.
GO:0000792 heterochromatin
IEA
GO_REF:0000107
UNDECIDED
Summary: Normal heterochromatin targeting is uncertain for this PWWP-altered model.
Reason: The selected sequence lacks human339–374, overlapping the PWWP reader. Human PWWP variants alter histone recognition and genomic methylation, so exact chromatin targeting cannot be inferred from an intact catalytic domain.
Supporting Evidence:
PMID:30478443
Substitutions in the PWWP domain abrogate binding to the histone modifications H3K36me2 and H3K36me3, and alter DNA methylation in patient cells.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
The ADD domain (human 482–614) and C-terminal methyltransferase domain (634–912) are retained.
GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding
IEA
GO_REF:0000107
UNDECIDED
Summary: The proposed cis-regulatory sequence specificity needs independent support.
Reason: DNMT3A binds substrate DNA, but regulatory-site occupancy can be mediated by transcription factors. Neither the broad catalytic function nor the altered horse chromatin-reader region establishes this specific transcription-factor-like DNA-binding term.
Supporting Evidence:
PMID:29414941
Arg836 of the target recognition domain makes crucial contacts with CpG, ensuring DNMT3A enzymatic preference towards CpG sites in cells.
PMID:19786833
the invalidation of c-myc reveals that c-myc allows the Dnmt3a recruitment on c-myc box of c-myc-regulated genes.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
The ADD domain (human 482–614) and C-terminal methyltransferase domain (634–912) are retained.
GO:0001741 XY body
IEA
GO_REF:0000107
UNDECIDED
Summary: This specialized recruitment or germline function needs target-specific transfer evidence.
Reason: Conserved methyltransferase activity is insufficient to establish a particular lncRNA/transcription-factor partner or specialized germ-cell pathway. The PWWP deletion adds uncertainty about normal genomic recruitment; the horse testis expression study is not a functional perturbation.
Supporting Evidence:
PMID:38705424
Immunofluorescence of DNMT1, DNMT3a and DNMT3b on testis samples confirmed the differential expression and localization of these three DNA methylation transferases during horse development.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
The ADD domain (human 482–614) and C-terminal methyltransferase domain (634–912) are retained.
PMID:29414941
the DNMT3A-DNMT3L-DNA complex in which two DNMT3A monomers simultaneously attack two cytosine-phosphate-guanine (CpG) dinucleotides
GO:0003677 DNA binding
IEA
GO_REF:0000107
ACCEPT
Summary: The conserved DNMT3A catalytic apparatus supports DNA recognition and methyltransferase-complex function.
Reason: The ADD and C-terminal catalytic domains remain in a near-identical horse sequence, matching primary biochemical/structural evidence for the family. The PWWP lesion concerns targeting and does not itself remove this catalytic apparatus.
Supporting Evidence:
PMID:29414941
the DNMT3A-DNMT3L-DNA complex in which two DNMT3A monomers simultaneously attack two cytosine-phosphate-guanine (CpG) dinucleotides
PMID:29414941
Arg836 of the target recognition domain makes crucial contacts with CpG, ensuring DNMT3A enzymatic preference towards CpG sites in cells.
PMID:25383530
Histone H3 (but not H3K4me3) disrupts ADD-CD interaction, induces a large movement of the ADD domain, and thus releases the autoinhibition of DNMT3A.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
share 97.3% identity among 873 paired residues.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
The ADD domain (human 482–614) and C-terminal methyltransferase domain (634–912) are retained.
GO:0003886 DNA (cytosine-5-)-methyltransferase activity
IBA
GO_REF:0000033
ACCEPT
Summary: The conserved DNMT3A catalytic apparatus supports DNA recognition and methyltransferase-complex function.
Reason: The ADD and C-terminal catalytic domains remain in a near-identical horse sequence, matching primary biochemical/structural evidence for the family. The PWWP lesion concerns targeting and does not itself remove this catalytic apparatus.
Supporting Evidence:
PMID:29414941
the DNMT3A-DNMT3L-DNA complex in which two DNMT3A monomers simultaneously attack two cytosine-phosphate-guanine (CpG) dinucleotides
PMID:29414941
Arg836 of the target recognition domain makes crucial contacts with CpG, ensuring DNMT3A enzymatic preference towards CpG sites in cells.
PMID:25383530
Histone H3 (but not H3K4me3) disrupts ADD-CD interaction, induces a large movement of the ADD domain, and thus releases the autoinhibition of DNMT3A.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
share 97.3% identity among 873 paired residues.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
The ADD domain (human 482–614) and C-terminal methyltransferase domain (634–912) are retained.
GO:0003886 DNA (cytosine-5-)-methyltransferase activity
IEA
GO_REF:0000120
ACCEPT
Summary: The conserved DNMT3A catalytic apparatus supports DNA recognition and methyltransferase-complex function.
Reason: The ADD and C-terminal catalytic domains remain in a near-identical horse sequence, matching primary biochemical/structural evidence for the family. The PWWP lesion concerns targeting and does not itself remove this catalytic apparatus.
Supporting Evidence:
PMID:29414941
the DNMT3A-DNMT3L-DNA complex in which two DNMT3A monomers simultaneously attack two cytosine-phosphate-guanine (CpG) dinucleotides
PMID:29414941
Arg836 of the target recognition domain makes crucial contacts with CpG, ensuring DNMT3A enzymatic preference towards CpG sites in cells.
PMID:25383530
Histone H3 (but not H3K4me3) disrupts ADD-CD interaction, induces a large movement of the ADD domain, and thus releases the autoinhibition of DNMT3A.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
share 97.3% identity among 873 paired residues.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
The ADD domain (human 482–614) and C-terminal methyltransferase domain (634–912) are retained.
GO:0005634 nucleus
IBA
GO_REF:0000033
ACCEPT
Summary: A nuclear DNMT3A pool is supported.
Reason: Human imaging and conserved chromatin/catalytic machinery support nuclear/nucleoplasmic localization. Horse testis immunofluorescence demonstrates a DNMT3A protein pool but the cached abstract does not provide the detailed subcellular distribution or establish identity with this exact model.
Supporting Evidence:
PMID:23042785
co-expression of WT1 and DNMT3A proteins in nuclei of blastemal cells in human fetal kidney and Wilms' tumours.
PMID:12138111
Unlike Dnmt3a, which was concentrated on heterochromatin, Dnmt3a2 displayed a localization pattern suggestive of euchromatin association.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
share 97.3% identity among 873 paired residues.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
The ADD domain (human 482–614) and C-terminal methyltransferase domain (634–912) are retained.
PMID:38705424
Immunofluorescence of DNMT1, DNMT3a and DNMT3b on testis samples confirmed the differential expression and localization of these three DNA methylation transferases during horse development.
GO:0005634 nucleus
IEA
GO_REF:0000120
ACCEPT
Summary: A nuclear DNMT3A pool is supported.
Reason: Human imaging and conserved chromatin/catalytic machinery support nuclear/nucleoplasmic localization. Horse testis immunofluorescence demonstrates a DNMT3A protein pool but the cached abstract does not provide the detailed subcellular distribution or establish identity with this exact model.
Supporting Evidence:
PMID:23042785
co-expression of WT1 and DNMT3A proteins in nuclei of blastemal cells in human fetal kidney and Wilms' tumours.
PMID:12138111
Unlike Dnmt3a, which was concentrated on heterochromatin, Dnmt3a2 displayed a localization pattern suggestive of euchromatin association.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
share 97.3% identity among 873 paired residues.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
The ADD domain (human 482–614) and C-terminal methyltransferase domain (634–912) are retained.
PMID:38705424
Immunofluorescence of DNMT1, DNMT3a and DNMT3b on testis samples confirmed the differential expression and localization of these three DNA methylation transferases during horse development.
GO:0005654 nucleoplasm
IEA
GO_REF:0000107
ACCEPT
Summary: A nuclear DNMT3A pool is supported.
Reason: Human imaging and conserved chromatin/catalytic machinery support nuclear/nucleoplasmic localization. Horse testis immunofluorescence demonstrates a DNMT3A protein pool but the cached abstract does not provide the detailed subcellular distribution or establish identity with this exact model.
Supporting Evidence:
PMID:23042785
co-expression of WT1 and DNMT3A proteins in nuclei of blastemal cells in human fetal kidney and Wilms' tumours.
PMID:12138111
Unlike Dnmt3a, which was concentrated on heterochromatin, Dnmt3a2 displayed a localization pattern suggestive of euchromatin association.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
share 97.3% identity among 873 paired residues.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
The ADD domain (human 482–614) and C-terminal methyltransferase domain (634–912) are retained.
PMID:38705424
Immunofluorescence of DNMT1, DNMT3a and DNMT3b on testis samples confirmed the differential expression and localization of these three DNA methylation transferases during horse development.
GO:0005737 cytoplasm
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: A cytoplasmic DNMT3A pool is compatible with mammalian localization.
Reason: Retain the additional ortholog/phylogenetic localization. It is not the principal compartment for DNA methylation, and the horse expression study does not determine its biochemical role.
Supporting Evidence:
PMID:12138111
Unlike Dnmt3a, which was concentrated on heterochromatin, Dnmt3a2 displayed a localization pattern suggestive of euchromatin association.
PMID:38705424
Immunofluorescence of DNMT1, DNMT3a and DNMT3b on testis samples confirmed the differential expression and localization of these three DNA methylation transferases during horse development.
GO:0005737 cytoplasm
IEA
GO_REF:0000120
KEEP AS NON CORE
Summary: A cytoplasmic DNMT3A pool is compatible with mammalian localization.
Reason: Retain the additional ortholog/phylogenetic localization. It is not the principal compartment for DNA methylation, and the horse expression study does not determine its biochemical role.
Supporting Evidence:
PMID:12138111
Unlike Dnmt3a, which was concentrated on heterochromatin, Dnmt3a2 displayed a localization pattern suggestive of euchromatin association.
PMID:38705424
Immunofluorescence of DNMT1, DNMT3a and DNMT3b on testis samples confirmed the differential expression and localization of these three DNA methylation transferases during horse development.
GO:0006346 DNA methylation-dependent constitutive heterochromatin formation
IEA
GO_REF:0000107
UNDECIDED
Summary: Normal heterochromatin targeting is uncertain for this PWWP-altered model.
Reason: The selected sequence lacks human339–374, overlapping the PWWP reader. Human PWWP variants alter histone recognition and genomic methylation, so exact chromatin targeting cannot be inferred from an intact catalytic domain.
Supporting Evidence:
PMID:30478443
Substitutions in the PWWP domain abrogate binding to the histone modifications H3K36me2 and H3K36me3, and alter DNA methylation in patient cells.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
The ADD domain (human 482–614) and C-terminal methyltransferase domain (634–912) are retained.
GO:0008168 methyltransferase activity
IEA
GO_REF:0000002
MODIFY
Summary: The specific methyl acceptor is DNA cytosine.
Reason: The conserved C-terminal apparatus supports DNA cytosine-5 methyltransferase activity rather than an unspecified methyltransferase.
Supporting Evidence:
PMID:29414941
the DNMT3A-DNMT3L-DNA complex in which two DNMT3A monomers simultaneously attack two cytosine-phosphate-guanine (CpG) dinucleotides
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
The ADD domain (human 482–614) and C-terminal methyltransferase domain (634–912) are retained.
GO:0010468 regulation of gene expression
IEA
GO_REF:0000002
ACCEPT
Summary: The retained DNMT3A catalytic machinery supports gene-expression regulation.
Reason: The ADD and methyltransferase domains are conserved, supporting targeted DNA methylation and transcriptional effects. A PWWP deletion can change genomic targeting without eliminating the broad regulatory function.
Supporting Evidence:
PMID:29414941
the DNMT3A-DNMT3L-DNA complex in which two DNMT3A monomers simultaneously attack two cytosine-phosphate-guanine (CpG) dinucleotides
PMID:23042785
DNMT3A recruitment is increased, with hypermethylation being associated with silencing of gene expression.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
share 97.3% identity among 873 paired residues.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
The ADD domain (human 482–614) and C-terminal methyltransferase domain (634–912) are retained.
PMID:30478443
Substitutions in the PWWP domain abrogate binding to the histone modifications H3K36me2 and H3K36me3, and alter DNA methylation in patient cells.
GO:0016363 nuclear matrix
IEA
GO_REF:0000107
UNDECIDED
Summary: A specific nuclear-matrix association is not established for this horse model.
Reason: Conserved nuclear localization does not resolve subnuclear fractionation, particularly with an altered chromatin-reader region.
Supporting Evidence:
PMID:12138111
Unlike Dnmt3a, which was concentrated on heterochromatin, Dnmt3a2 displayed a localization pattern suggestive of euchromatin association.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
The ADD domain (human 482–614) and C-terminal methyltransferase domain (634–912) are retained.
GO:0031048 regulatory ncRNA-mediated heterochromatin formation
IEA
GO_REF:0000107
UNDECIDED
Summary: This specialized recruitment or germline function needs target-specific transfer evidence.
Reason: Conserved methyltransferase activity is insufficient to establish a particular lncRNA/transcription-factor partner or specialized germ-cell pathway. The PWWP deletion adds uncertainty about normal genomic recruitment; the horse testis expression study is not a functional perturbation.
Supporting Evidence:
PMID:38705424
Immunofluorescence of DNMT1, DNMT3a and DNMT3b on testis samples confirmed the differential expression and localization of these three DNA methylation transferases during horse development.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
The ADD domain (human 482–614) and C-terminal methyltransferase domain (634–912) are retained.
PMID:29414941
the DNMT3A-DNMT3L-DNA complex in which two DNMT3A monomers simultaneously attack two cytosine-phosphate-guanine (CpG) dinucleotides
GO:0042802 identical protein binding
IEA
GO_REF:0000107
ACCEPT
Summary: The retained catalytic interface supports DNMT3A self-association.
Reason: Human structures and mutant coexpression establish oligomeric catalysis; the horse C-terminal domain is retained.
Supporting Evidence:
PMID:24656771
coexpression of the two proteins in cells profoundly inhibits the WT enzyme by disrupting its ability to homotetramerize.
PMID:29414941
the DNMT3A-DNMT3L-DNA complex in which two DNMT3A monomers simultaneously attack two cytosine-phosphate-guanine (CpG) dinucleotides
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
The ADD domain (human 482–614) and C-terminal methyltransferase domain (634–912) are retained.
GO:0044027 negative regulation of gene expression via chromosomal CpG island methylation
IEA
GO_REF:0000107
ACCEPT
Summary: The retained DNMT3A catalytic machinery supports gene-expression regulation.
Reason: The ADD and methyltransferase domains are conserved, supporting targeted DNA methylation and transcriptional effects. A PWWP deletion can change genomic targeting without eliminating the broad regulatory function.
Supporting Evidence:
PMID:29414941
the DNMT3A-DNMT3L-DNA complex in which two DNMT3A monomers simultaneously attack two cytosine-phosphate-guanine (CpG) dinucleotides
PMID:23042785
DNMT3A recruitment is increased, with hypermethylation being associated with silencing of gene expression.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
share 97.3% identity among 873 paired residues.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
The ADD domain (human 482–614) and C-terminal methyltransferase domain (634–912) are retained.
PMID:30478443
Substitutions in the PWWP domain abrogate binding to the histone modifications H3K36me2 and H3K36me3, and alter DNA methylation in patient cells.
GO:0045892 negative regulation of DNA-templated transcription
IBA
GO_REF:0000033
ACCEPT
Summary: The retained DNMT3A catalytic machinery supports gene-expression regulation.
Reason: The ADD and methyltransferase domains are conserved, supporting targeted DNA methylation and transcriptional effects. A PWWP deletion can change genomic targeting without eliminating the broad regulatory function.
Supporting Evidence:
PMID:29414941
the DNMT3A-DNMT3L-DNA complex in which two DNMT3A monomers simultaneously attack two cytosine-phosphate-guanine (CpG) dinucleotides
PMID:23042785
DNMT3A recruitment is increased, with hypermethylation being associated with silencing of gene expression.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
share 97.3% identity among 873 paired residues.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
The ADD domain (human 482–614) and C-terminal methyltransferase domain (634–912) are retained.
PMID:30478443
Substitutions in the PWWP domain abrogate binding to the histone modifications H3K36me2 and H3K36me3, and alter DNA methylation in patient cells.
GO:0061629 RNA polymerase II-specific DNA-binding transcription factor binding
IEA
GO_REF:0000107
UNDECIDED
Summary: This specialized recruitment or germline function needs target-specific transfer evidence.
Reason: Conserved methyltransferase activity is insufficient to establish a particular lncRNA/transcription-factor partner or specialized germ-cell pathway. The PWWP deletion adds uncertainty about normal genomic recruitment; the horse testis expression study is not a functional perturbation.
Supporting Evidence:
PMID:38705424
Immunofluorescence of DNMT1, DNMT3a and DNMT3b on testis samples confirmed the differential expression and localization of these three DNA methylation transferases during horse development.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
The ADD domain (human 482–614) and C-terminal methyltransferase domain (634–912) are retained.
PMID:29414941
the DNMT3A-DNMT3L-DNA complex in which two DNMT3A monomers simultaneously attack two cytosine-phosphate-guanine (CpG) dinucleotides
GO:0106222 lncRNA binding
IEA
GO_REF:0000120
UNDECIDED
Summary: This specialized recruitment or germline function needs target-specific transfer evidence.
Reason: Conserved methyltransferase activity is insufficient to establish a particular lncRNA/transcription-factor partner or specialized germ-cell pathway. The PWWP deletion adds uncertainty about normal genomic recruitment; the horse testis expression study is not a functional perturbation.
Supporting Evidence:
PMID:38705424
Immunofluorescence of DNMT1, DNMT3a and DNMT3b on testis samples confirmed the differential expression and localization of these three DNA methylation transferases during horse development.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
The ADD domain (human 482–614) and C-terminal methyltransferase domain (634–912) are retained.
PMID:29414941
the DNMT3A-DNMT3L-DNA complex in which two DNMT3A monomers simultaneously attack two cytosine-phosphate-guanine (CpG) dinucleotides
GO:0106363 protein-cysteine methyltransferase activity
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: Cysteine automethylation is a plausible conserved side reaction.
Reason: Mouse Dnmt3a exhibits slow catalytic-cysteine automethylation in DNA-free assays. Conservation of the catalytic region makes this capacity plausible, but neither horse evidence nor the source paper establishes a physiological protein-methylation role.
Supporting Evidence:
PMID:21481189
In the presence of CpG containing dsDNA, which is the natural substrate for Dnmt3a, the transfer of the methyl group from AdoMet to the flipped target base was preferred and auto-methylation was not detected.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
The ADD domain (human 482–614) and C-terminal methyltransferase domain (634–912) are retained.
GO:0141196 transposable element silencing by piRNA-mediated DNA methylation
IEA
GO_REF:0000107
UNDECIDED
Summary: This specialized recruitment or germline function needs target-specific transfer evidence.
Reason: Conserved methyltransferase activity is insufficient to establish a particular lncRNA/transcription-factor partner or specialized germ-cell pathway. The PWWP deletion adds uncertainty about normal genomic recruitment; the horse testis expression study is not a functional perturbation.
Supporting Evidence:
PMID:38705424
Immunofluorescence of DNMT1, DNMT3a and DNMT3b on testis samples confirmed the differential expression and localization of these three DNA methylation transferases during horse development.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
The ADD domain (human 482–614) and C-terminal methyltransferase domain (634–912) are retained.
PMID:29414941
the DNMT3A-DNMT3L-DNA complex in which two DNMT3A monomers simultaneously attack two cytosine-phosphate-guanine (CpG) dinucleotides
GO:1902494 catalytic complex
IEA
GO_REF:0000107
ACCEPT
Summary: The conserved DNMT3A catalytic apparatus supports DNA recognition and methyltransferase-complex function.
Reason: The ADD and C-terminal catalytic domains remain in a near-identical horse sequence, matching primary biochemical/structural evidence for the family. The PWWP lesion concerns targeting and does not itself remove this catalytic apparatus.
Supporting Evidence:
PMID:29414941
the DNMT3A-DNMT3L-DNA complex in which two DNMT3A monomers simultaneously attack two cytosine-phosphate-guanine (CpG) dinucleotides
PMID:29414941
Arg836 of the target recognition domain makes crucial contacts with CpG, ensuring DNMT3A enzymatic preference towards CpG sites in cells.
PMID:25383530
Histone H3 (but not H3K4me3) disrupts ADD-CD interaction, induces a large movement of the ADD domain, and thus releases the autoinhibition of DNMT3A.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
share 97.3% identity among 873 paired residues.
file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
The ADD domain (human 482–614) and C-terminal methyltransferase domain (634–912) are retained.

Core Functions

Conserved DNA methyltransferase supporting gene-expression regulation, with altered PWWP-guided targeting unresolved.

Supporting Evidence:
  • PMID:29414941
    the DNMT3A-DNMT3L-DNA complex in which two DNMT3A monomers simultaneously attack two cytosine-phosphate-guanine (CpG) dinucleotides
  • PMID:23042785
    DNMT3A recruitment is increased, with hypermethylation being associated with silencing of gene expression.
  • PMID:23042785
    co-expression of WT1 and DNMT3A proteins in nuclei of blastemal cells in human fetal kidney and Wilms' tumours.
  • file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
    share 97.3% identity among 873 paired residues.
  • file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md
    The ADD domain (human 482–614) and C-terminal methyltransferase domain (634–912) are retained.

References

Loading supporting content…

Download this section (compressed HTML)

External Prediction Reviews

These computational predictions are reviewed separately from the GOA annotation set used for this review. The assessments below are from this project and do not constitute official GO annotations or endorsement by GO/UniProt. They are not included in the existing annotation review above.

ProtNLM2 External predictions

View prediction review YAML Β· DNMT3A-protnlm-predictions-review.yaml Β· Review status: COMPLETE

Nuclear localization and gene-expression regulation are supported; the PWWP-region deletion limits more specific targeting claims.

Source documents: projects/PROTNLM_EVALUATION/mammal-benchmark/horse40-predictions.csv Β· projects/PROTNLM_EVALUATION/mammal-benchmark/predictions.jsonl.gz Β· projects/PROTNLM_EVALUATION/mammal-benchmark/paired-sequences/DNMT3A.json

Review score: 2 = concordant with evidence; 1 = uncertain; 0 = discordant with evidence. This is an assessment score, not a model probability.

GO:0010468 regulation of gene expression GO_BP
CNN β€” Correct but not novel Review score: 2/2
Prediction method: ProtNLM2 Β· Version: UniProt API snapshot 2026-09-08
Review rationale: Gene-expression regulation follows from the conserved DNA methyltransferase mechanism and is already present in frozen horse GOA. The PWWP-region deletion can alter which loci are methylated without abolishing the broad function. This known-target classification denotes overlap with the frozen annotation snapshot, not verified presence in ProtNLM training data.
Supporting Evidence:
  • PMID:29414941: "the DNMT3A-DNMT3L-DNA complex in which two DNMT3A monomers simultaneously attack two cytosine-phosphate-guanine (CpG) dinucleotides"
  • PMID:23042785: "DNMT3A recruitment is increased, with hypermethylation being associated with silencing of gene expression."
  • PMID:30478443: "Substitutions in the PWWP domain abrogate binding to the histone modifications H3K36me2 and H3K36me3, and alter DNA methylation in patient cells."
  • file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md: "share 97.3% identity among 873 paired residues."
  • file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md: "The ADD domain (human 482–614) and C-terminal methyltransferase domain (634–912) are retained."
GO:0005634 nucleus GO_CC
LSP β€” Less precise than existing annotation Review score: 2/2
Prediction method: ProtNLM2 Β· Version: UniProt API snapshot 2026-09-08
Review rationale: Human imaging directly establishes a nuclear DNMT3A pool, and the horse model retains the chromatin-associated ADD/catalytic apparatus. The frozen horse GOA contains the more specific nucleoplasm term, supported by this same biological rationale. Horse testis protein-expression evidence is relevant but does not identify this accession or resolve precise compartments in the cached abstract.
Supporting Evidence:
  • PMID:23042785: "co-expression of WT1 and DNMT3A proteins in nuclei of blastemal cells in human fetal kidney and Wilms' tumours."
  • PMID:12138111: "Unlike Dnmt3a, which was concentrated on heterochromatin, Dnmt3a2 displayed a localization pattern suggestive of euchromatin association."
  • file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md: "share 97.3% identity among 873 paired residues."
  • file:HORSE/DNMT3A/DNMT3A-bioinformatics/RESULTS.md: "The ADD domain (human 482–614) and C-terminal methyltransferase domain (634–912) are retained."
  • PMID:38705424: "Immunofluorescence of DNMT1, DNMT3a and DNMT3b on testis samples confirmed the differential expression and localization of these three DNA methylation transferases during horse development."

Deep Research

Falcon

(DNMT3A-deep-research-falcon.md)

Loading supporting content…

Download this section (compressed HTML)

πŸ“š Additional Documentation

Notes

(DNMT3A-notes.md)

Loading supporting content…

Download this section (compressed HTML)

Bioinformatics Results

(RESULTS.md)

Loading supporting content…

Download this section (compressed HTML)

πŸ“„ View Raw YAML

Loading supporting content…

Download this section (compressed HTML)